Safe and sustainable PFMD eye care

Nemera plays a leading role in enabling safe, user-friendly preservative-free delivery across ophthalmic therapies. Through its Novelia® platform, the company offers a multidose device that prevents microbial growth over treatment duration and eliminates the need for preservatives in formulations. Séverine Duband, Strategy & Marketing Director, Ophthalmics and Respiratory Business Unit, Nemera, describes Nemera’s end-to-end combination product services, including analytical testing, design verification, human-factors validation, and regulatory strategy to help pharma partners accelerate development in the ocular space.

Please explain how Novelia makes daily administration easier and safer for patients.

Séverine Duband: Features like a human-centric design, configurable performance, and microbial protection make Novelia a reference for safe, comfortable, and sustainable PFMD eye care. Novelia makes daily administration easier, safer, and more comfortable. The soft, ergonomic bottle and patented blue nozzle tip help users target the eye with greater accuracy, while our technology maintains safety and performance drop after drop. Together, these features enhance trust and comfort—helping patients adhere to their therapy and experience better quality of life.

How do care givers benefit from Novelia?

S.D.: For care providers, Novelia simplifies treatment management and supports better clinical outcomes by improving dose precision and patient adherence. Consistent one-drop delivery helps ensure the prescribed therapeutic dose is achieved every time, while the preservative-free design reduces the risk of ocular irritation and droprelated discontinuation—issues that often complicate chronic eye care management. The device’s proven microbiological integrity – supported by stability studies conducted on the combination product - also gives healthcare professionals confidence in long term sterility and product safety across the treatment duration

Read the full article here: Interview SD TPP JAN 26 - PFMD EYE CARE